| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ |
|---|---|---|---|---|
| Revenue | $4.7B | $3.5B | $2.4B | $2.0B |
| Cost of Revenue | — | — | — | — |
| Gross Profit | — | — | — | — |
| R&D Expense | — | — | — | — |
| SG&A Expense | — | — | — | — |
| Operating Income | — | — | — | — |
| Net Income | $0.2B | $0.0B | $0.1B | $0.1B |
| EPS (Basic) | $0.89 | $0.00 | $0.89 | $1.10 |
| EPS (Diluted) | $0.45 | $-0.42 | $-0.04 | $-0.19 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ |
|---|---|---|---|---|
| Total Assets | $13.5B | $10.5B | $9.4B | $7.9B |
| Current Assets | — | — | — | — |
| Cash & Equivalents | $0.8B | $0.8B | $0.7B | $1.1B |
| Total Liabilities | $9.4B | $6.9B | $6.0B | $4.2B |
| Current Liabilities | — | — | — | — |
| Stockholders' Equity | — | — | — | — |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ |
|---|---|---|---|---|
| Operating Cash Flow | $1.0B | $0.5B | $0.7B | $1.4B |
| Investing Cash Flow | $-0.3B | $-0.0B | $-0.4B | $-0.0B |
| Capital Expenditures | — | — | — | — |
| Financing Cash Flow | $-0.8B | $-0.3B | $-0.8B | $-1.2B |